Fusion Antibodies

Since 2001, Fusion Antibodies has been dedicated to the discovery and early development of antibodies to help bring about a positive change in the healthcare industry. We offer a complete range of antibody-related services in Discovery, Engineering and Supply and have guided hundreds of projects through critical preclinical stages. Fifteen of our clients projects have advanced to clinical stages, some as far as Phase II. We deliver a superior service for the development of antibodies by beginning each project with the end in mind. Our scientists are experts in early stage discovery of biologics. We offer this personalised service because...

Antibody humanization,protein expression & purification services,monoclonal antibody services blast & standard,antibody sequencing services,invitro diagnostic proteins,antibody engineering,cell line development,affinity maturation services,and antibody developability by design

Fusion antibodies operates in the Biotechnology research industry.

Fusion antibodies's revenue is 1m - 10m

Fusion antibodies has 11 - 50 employees.